Strong Growth in Innovative Drug Revenue, Biopharmaceutical Companies' Performance Shows High "Innovation" ContentWallstreetcn·Mar 29 at 05:41 PM588250+0.91%159992+1.57%
MicuRx: Net loss of 54.8617 million yuan in the third quarterZhitong·Oct 27, 2025 at 06:18 AM688373+2.49%
MicuRx Pharmaceuticals has reached a strategic cooperation agreement with Pengbo Biotech for the joint development of ADC drugsZhitong·Sep 26, 2025 at 12:24 AM688373+2.49%
MicuRx shareholders Genie Pharma propose to add a temporary proposal regarding the removal and election of directorsZhitong·Sep 24, 2025 at 09:51 AM688373+2.49%
MicuRx shareholders Genie Pharma publicly solicit votes to oppose certain proposalsZhitong·Sep 24, 2025 at 09:39 AM688373+2.49%
MicuRx Pharmaceuticals signed a strategic cooperation agreement with Haiqing PharmaceuticalsZhitong·Sep 22, 2025 at 09:20 AM688373+2.49%
MicuRx plans to raise no more than 1.033 billion yuan through a private placement to HaiJing Pharmaceutical for research and operational investmentZhitong·Sep 22, 2025 at 09:14 AM688373+2.49%
MicuRx shareholders plan to reduce their holdings by no more than 6%Zhitong·Sep 9, 2025 at 07:45 AM688373+2.49%
MicuRx: Net loss of 139 million yuan in the first half of 2025Zhitong·Aug 19, 2025 at 07:36 AM688373+2.49%
MicuRx: Shareholder MicuRx Hong Kong plans to reduce its holdings by no more than 3% of the company's sharesZhitong·Aug 14, 2025 at 06:33 AM688373+2.49%
Zhitong A-share lock-up release overview | August 5Zhitong·Aug 4, 2025 at 08:01 PM688373+2.49%301308+2.42%
MicuRx: The new drug application for injectable Contizolam Sodium has been acceptedZhitong·May 21, 2025 at 06:14 AM688373+2.49%
MicuRx: Net loss of 61.6325 million yuan in the first quarter of 2025Zhitong·Apr 23, 2025 at 04:04 AM688373+2.49%
MicuRx will present 15 studies at ESCMID Global 2025 in Vienna from April 11-15, showcasing research in microbiology.Unusual Whales·Apr 8, 2025 at 03:02 AM688373+2.49%
